Bibliography

Cantuti-Castelvetri, Ludovico, et al. “Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity.” Science, vol. 370, no. 6518, 20 Oct. 2020, science.sciencemag.org/content/early/2020/10/19/science.abd2985, https://doi.org/10.1126/science.abd2985.

Kyrou, Ioannis, et al. “Not Only ACE2—the Quest for Additional Host Cell Mediators of SARS-CoV-2 Infection: Neuropilin-1 (NRP1) as a Novel SARS-CoV-2 Host Cell Entry Mediator Implicated in COVID-19.” Signal Transduction and Targeted Therapy, vol. 6, no. 1, 18 Jan. 2021, https://doi.org/10.1038/s41392-020-00460-9. Accessed 28 Jan. 2021.

Li, Zhenhua, et al. “Cell-Mimicking Nanodecoys Neutralize SARS-CoV-2 and Mitigate Lung Injury in a Non-Human Primate Model of COVID-19.” Nature Nanotechnology, vol. 16, no. 8, 17 June 2021, pp. 942–951, https://doi.org/10.1038/s41565-021-00923-2. Accessed 14 Dec. 2023.

Mayi, Bindu S., et al. “The Role of Neuropilin-1 in COVID-19.” PLOS Pathogens, vol. 17, no. 1, 4 Jan. 2021, p. e1009153, https://doi.org/10.1371/journal.ppat.1009153.

Lim, Key-Hwan, et al. “Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer’s Disease Patients Group Brain Using Genome-Wide Association Study Approach.” Frontiers in Genetics, vol. 12, Oct. 2021. Frontiers, https://doi.org/10.3389/fgene.2021.741175.

Hosseini, Faezeh, et al. “Neuropilin‐1 as a Neuroinflammatory Entry Factor for SARS‐CoV‐2 Is Attenuated in Vaccinated COVID‐19 Patients: A Case–Control Study.” Health Science Reports, vol. 8, no. 4, Apr. 2025, p. e70630. PubMed Central, https://doi.org/10.1002/hsr2.70630.

Nguyen, Hoang Linh, et al. “Neuropilin-1 Protein May Serve as a Receptor for SARS-CoV-2 Infection: Evidence from Molecular Dynamics Simulations.” The Journal of Physical Chemistry B, vol. 128, no. 29, July 2024, pp. 7141–47. DOI.org (Crossref), https://doi.org/10.1021/acs.jpcb.4c03119.

Dette, A., et al. “Differential Expression of Viral Entry Protein Neuropilin 1 (NRP1) and Neuropilin 2 (NRP2) in Fatal COVID-19.” Journal of Virology, edited by Stacey Schultz-Cherry, vol. 99, no. 11, Nov. 2025, pp. e01384-25. DOI.org (Crossref), https://doi.org/10.1128/jvi.01384-25.

Saleki, Kiarash, et al. “Is Neuropilin-1 the Neuroimmune Initiator of Multi-System Hyperinflammation in COVID-19?” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 167, Nov. 2023, p. 115558. PubMed, https://doi.org/10.1016/j.biopha.2023.115558.

Hou, Decheng, et al. “Biophysical Investigation of Interactions between SARS‐CoV ‐2 Spike Protein and Neuropilin‐1.” Protein Science, vol. 32, no. 10, Oct. 2023, p. e4773. DOI.org (Crossref), https://doi.org/10.1002/pro.4773.

Gaudin, Raphael, et al. “Targeting Tight Junctions to Fight against Viral Neuroinvasion.” Trends in Molecular Medicine, vol. 28, no. 1, Jan. 2022, pp. 12–24. ScienceDirect, https://doi.org/10.1016/j.molmed.2021.10.007.

Chen, Zhuangzhuang, and Guozhong Li. “Immune Response and Blood–Brain Barrier Dysfunction during Viral Neuroinvasion.” Innate Immunity, vol. 27, no. 2, Feb. 2021, pp. 109–17. DOI.org (Crossref), https://doi.org/10.1177/1753425920954281.

CDC. “Respiratory Illnesses.” Respiratory Illnesses, 6 Jan. 2026, https://www.cdc.gov/respiratory-viruses/index.html.

Song, Eric, et al. “Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain.” Journal of Experimental Medicine, vol. 218, no. 3, Mar. 2021, p. e20202135. DOI.org (Crossref), https://doi.org/10.1084/jem.20202135.

Varatharaj, Aravinthan, et al. “Neurological and Neuropsychiatric Complications of COVID-19 in 153 Patients: A UK-Wide Surveillance Study.” The Lancet Psychiatry, vol. 7, no. 10, Oct. 2020, pp. 875–82. DOI.org (Crossref), https://doi.org/10.1016/S2215-0366(20)30287-X.

Puelles, Victor G., et al. “Multiorgan and Renal Tropism of SARS-CoV-2.” New England Journal of Medicine, vol. 383, no. 6, Aug. 2020, pp. 590–92. DOI.org (Crossref), https://doi.org/10.1056/NEJMc2011400.

Kong, Weili, et al. “Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons.” mBio, edited by Matthew S. Miller, vol. 13, no. 6, Dec. 2022, pp. e02308-22. DOI.org (Crossref), https://doi.org/10.1128/mbio.02308-22.

Editor, ICNS Online. “Molecular and Cellular Mechanisms Underlying Neurological and Neuropsychological Manifestations of COVID-19.” Innovations in Clinical Neuroscience, 1 Dec. 2025, https://innovationscns.com/molecular-and-cellular-mechanisms-underlying-neurological-and-neuropsychological-manifestations-of-covid-19/.

Desforges, Marc, et al. “Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?” Viruses, vol. 12, no. 1, Dec. 2019, p. 14. DOI.org (Crossref), https://doi.org/10.3390/v12010014.

Lin, Zhu Yue, et al. “Pharmacological Basis and New Insights of Deguelin Concerning Its Anticancer Effects.” Pharmacological Research, vol. 174, Dec. 2021, p. 105935. DOI.org (Crossref), https://doi.org/10.1016/j.phrs.2021.105935.

Schwabenland, Marius, et al. “Deep Spatial Profiling of Human COVID-19 Brains Reveals Neuroinflammation with Distinct Microanatomical Microglia-T-Cell Interactions.” Immunity, vol. 54, no. 7, July 2021, pp. 1594-1610.e11. ScienceDirect, https://doi.org/10.1016/j.immuni.2021.06.002.

“A Paradigm Shift in Neurobiology: The Brain’s Anti-Inflammatory Circuitry Revealed.” SciTechDaily, 3 Aug. 2023, scitechdaily.com/a-paradigm-shift-in-neurobiology-the-brains-anti-inflammatory-circuitry-r. Accessed 31 Mar. 2026.

The Scientist. “Neuroinflammation.” The Scientist, 2026, www.the-scientist.com/tag/neuroinflammation. Accessed 31 Mar. 2026.

National Geographic Society. “Viruses | National Geographic Society.” Education.nationalgeographic.org, 20 May 2022, education.nationalgeographic.org/resource/viruses/.

News, Neuroscience. “Magnetic Resonance Imaging Shows Brain Inflammation in Vivo for the First Time.” Neuroscience News, 27 May 2022, https://neurosciencenews.com/neuroinflammation-imaging-20679/.

Streamline. “Warning Triangle.” Streamlinehq.com, 2026, www.streamlinehq.com/icons/download/warning-triangle--23994. Accessed 31 Mar. 2026.

Kelly, Rachel, et al. “Sequelae of Viral CNS Infections Including Outcomes, Mechanisms, and Knowledge Gaps.” Npj Viruses, vol. 3, no. 1, Nov. 2025, p. 79. www.nature.com, https://doi.org/10.1038/s44298-025-00160-7.

“Blood-Brain Barrier.” RIT Rochester Institute of Technology, https://www.rit.edu/spotlights/blood-brain-barrier. Accessed 31 Mar. 2026.

“Human Verification | Pngtree.” Pngtree.com, 2026, pngtree.com/so/stopwatch. Accessed 31 Mar. 2026.

Unsplash. “Beautiful Free Images & Pictures.” Unsplash, Unsplash, 2025, unsplash.com/.

Foundation, Blender. “Blender - The Free and Open Source 3D Creation Software — Blender.Org.” Blender, https://www.blender.org/. Accessed 31 Mar. 2026.

Business, Onshape, a PTC. Onshape | Product Development Platform. https://www.onshape.com/en/. Accessed 31 Mar. 2026.

​